Combining AstraZeneca, mRNA COVID-19 Vaccines Show Efficacy In Danish Study: Reuters


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


  • Combining AstraZeneca plc's (NASDAQ:AZN) COVID-19 vaccine with a second dose from either Pfizer Inc (NYSE:PFE) - BioNTech SE (NASDAQ:BNTX) or Moderna Inc's (NASDAQ:MRNAshot provides "good protection," Denmark's State Serum Institute (SSI) said.
  • More than 144,000 Danish citizens, mostly healthcare frontline personnel and the elderly, received their first jab from AstraZeneca and subsequent shot from either Pfizer-BioNTech or Moderna, reports Reuters.
  • "The study shows that fourteen days after a combined vaccination program, the risk of infection with SARS-CoV-2 is reduced by 88% compared to unvaccinated individuals," the SSI said.
  • That is a "high efficacy," SSI added, comparable to the 90% efficacy rate of two doses from Pfizer-BioNTech's vaccine, confirmed in a different Danish study. But the study could not conclude whether the same protection applied to the Delta-variant.
  • It also provided no efficacy data on COVID-19 related deaths or hospitalizations since none took place following the combined vaccination program.
  • Price Action: AZN shares are up 0.31% at $57.42 on the last check Monday.
  • Photo by Johaehn from Pixabay

Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

Posted In: BiotechNewsHealth CareGeneralBriefsCOVID-19 VaccineReuters